Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)
Clinical trial NCT05109598 · COMPLETED
Trial details
- NCT number
- NCT05109598
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2022-02-14
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.